相关实验视频

Updated: May 21, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

在胰腺癌中准PIKfyve驱动的脂质代谢

Caleb Cheng^1,2,3, Jing Hu^1,4,5, Rahul Mannan^1,4

¹Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.

|April 24, 2025

概括

在胰腺癌中向PIKfyve (PDAC) 干扰脂质代谢. 将PIKfyve抑制与KRAS- MAPK治疗结合起来,通过诱导合成致死性来消除瘤,从而提供了一种新的治疗策略.

科学领域:

癌症学
癌症新陈代谢
脂质生物学

背景情况:

胰腺管腺癌 (PDAC) 依赖于放松的微环境和自等代谢途径.
针对癌症新陈代谢是有前途的,但确定有效的药物点仍然具有挑战性.
PIKfyve 是一种对 lysosomal 功能至关重要的脂类激酶,与 PDAC 的进展有关.

研究的目的:

将PIKfyve描述为一个可针对的PDAC漏洞.
在PDAC中研究PIKfyve抑制的代谢后果.
在PDAC模型中评估PIKfyve和KRAS- MAPK通路联合抑制的疗效.

主要方法:

使用基因工程小鼠模型的PDAC.
进行了全面的代谢分析以了解PIKfyve的抑制作用.
在临床前模型中评估了同时PIKfyve和KRAS- MAPK向的影响.

主要成果:

PIKfyve对于PDAC的进展至关重要.
通过KRAS- MAPK信号,PIKfyve的抑制诱导了新型脂质合成的上调.
在临床前模型中,联合PIKfyve抑制和KRAS- MAPK向消除了瘤负担.

结论:

在PDAC中,PIKfyve是一个可用药的目标.
通过抑制PIKfyve来破坏脂质代谢导致合成致死性.
针对PIKfyve和KRAS- MAPK的组合疗法为PDAC提供了一个有前途的治疗策略.

更多相关视频

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...